JP7055992B2 - 心臓弁修復装置およびその植込み方法 - Google Patents
心臓弁修復装置およびその植込み方法 Download PDFInfo
- Publication number
- JP7055992B2 JP7055992B2 JP2018563776A JP2018563776A JP7055992B2 JP 7055992 B2 JP7055992 B2 JP 7055992B2 JP 2018563776 A JP2018563776 A JP 2018563776A JP 2018563776 A JP2018563776 A JP 2018563776A JP 7055992 B2 JP7055992 B2 JP 7055992B2
- Authority
- JP
- Japan
- Prior art keywords
- valve
- heart
- stent
- new
- leaflet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003709 heart valve Anatomy 0.000 title claims description 186
- 230000008439 repair process Effects 0.000 title claims description 117
- 238000000034 method Methods 0.000 title description 63
- 238000002513 implantation Methods 0.000 title description 12
- 238000011144 upstream manufacturing Methods 0.000 claims description 100
- 210000000591 tricuspid valve Anatomy 0.000 claims description 91
- 210000002216 heart Anatomy 0.000 claims description 71
- 210000003748 coronary sinus Anatomy 0.000 claims description 60
- 230000000087 stabilizing effect Effects 0.000 claims description 52
- 210000001631 vena cava inferior Anatomy 0.000 claims description 42
- 210000004115 mitral valve Anatomy 0.000 claims description 28
- 210000004369 blood Anatomy 0.000 claims description 23
- 239000008280 blood Substances 0.000 claims description 23
- 229920000642 polymer Polymers 0.000 claims description 14
- 210000004204 blood vessel Anatomy 0.000 claims description 11
- 210000003492 pulmonary vein Anatomy 0.000 claims description 11
- 230000000747 cardiac effect Effects 0.000 claims description 9
- 210000002620 vena cava superior Anatomy 0.000 claims description 9
- 239000004744 fabric Substances 0.000 claims description 5
- 210000001174 endocardium Anatomy 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims 1
- 210000005241 right ventricle Anatomy 0.000 description 61
- 210000001519 tissue Anatomy 0.000 description 59
- 210000005245 right atrium Anatomy 0.000 description 33
- 230000006870 function Effects 0.000 description 29
- 206010067171 Regurgitation Diseases 0.000 description 24
- 238000005304 joining Methods 0.000 description 22
- 230000002861 ventricular Effects 0.000 description 22
- 229910001092 metal group alloy Inorganic materials 0.000 description 18
- 230000004888 barrier function Effects 0.000 description 17
- 229910052751 metal Inorganic materials 0.000 description 17
- 239000002184 metal Substances 0.000 description 17
- 201000001943 Tricuspid Valve Insufficiency Diseases 0.000 description 15
- 206010044640 Tricuspid valve incompetence Diseases 0.000 description 15
- 150000002739 metals Chemical class 0.000 description 15
- 239000010936 titanium Substances 0.000 description 15
- 229910052719 titanium Inorganic materials 0.000 description 15
- 238000011282 treatment Methods 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 13
- 210000004379 membrane Anatomy 0.000 description 12
- 239000012528 membrane Substances 0.000 description 12
- 239000000227 bioadhesive Substances 0.000 description 9
- 210000002837 heart atrium Anatomy 0.000 description 9
- 210000003484 anatomy Anatomy 0.000 description 8
- 210000005246 left atrium Anatomy 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000002159 abnormal effect Effects 0.000 description 7
- 229910045601 alloy Inorganic materials 0.000 description 6
- 239000000956 alloy Substances 0.000 description 6
- 230000001746 atrial effect Effects 0.000 description 6
- -1 polypropylenes Polymers 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 210000003102 pulmonary valve Anatomy 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 229910018507 Al—Ni Inorganic materials 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 239000012237 artificial material Substances 0.000 description 5
- 230000010339 dilation Effects 0.000 description 5
- 229910001000 nickel titanium Inorganic materials 0.000 description 5
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 5
- 238000009864 tensile test Methods 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 210000001765 aortic valve Anatomy 0.000 description 4
- 210000003698 chordae tendineae Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229910000734 martensite Inorganic materials 0.000 description 4
- 210000003516 pericardium Anatomy 0.000 description 4
- 229920001643 poly(ether ketone) Polymers 0.000 description 4
- 210000001147 pulmonary artery Anatomy 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 206010067660 Heart valve incompetence Diseases 0.000 description 3
- 239000004696 Poly ether ether ketone Substances 0.000 description 3
- 206010039163 Right ventricular failure Diseases 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 210000000709 aorta Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 210000003191 femoral vein Anatomy 0.000 description 3
- 238000002594 fluoroscopy Methods 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 210000004731 jugular vein Anatomy 0.000 description 3
- 210000005240 left ventricle Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 229920002530 polyetherether ketone Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 210000001321 subclavian vein Anatomy 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000002592 echocardiography Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 208000018578 heart valve disease Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 208000002815 pulmonary hypertension Diseases 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000004248 Familial Primary Pulmonary Hypertension Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010048858 Ischaemic cardiomyopathy Diseases 0.000 description 1
- 208000020128 Mitral stenosis Diseases 0.000 description 1
- 206010027727 Mitral valve incompetence Diseases 0.000 description 1
- 229910000990 Ni alloy Inorganic materials 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical compound [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229910001566 austenite Inorganic materials 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 201000007119 infective endocarditis Diseases 0.000 description 1
- 230000003601 intercostal effect Effects 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 229940063711 lasix Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 208000006887 mitral valve stenosis Diseases 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000003540 papillary muscle Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 201000008312 primary pulmonary hypertension Diseases 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 229920001909 styrene-acrylic polymer Polymers 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 238000013175 transesophageal echocardiography Methods 0.000 description 1
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
- A61F2/2433—Deployment by mechanical expansion using balloon catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/246—Devices for obstructing a leak through a native valve in a closed condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201604791X | 2016-06-13 | ||
| SG10201604791X | 2016-06-13 | ||
| PCT/SG2017/050296 WO2017217932A1 (en) | 2016-06-13 | 2017-06-12 | Device for cardiac valve repair and method of implanting the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019517346A JP2019517346A (ja) | 2019-06-24 |
| JP2019517346A5 JP2019517346A5 (enExample) | 2020-07-02 |
| JP7055992B2 true JP7055992B2 (ja) | 2022-04-19 |
Family
ID=60663604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018563776A Active JP7055992B2 (ja) | 2016-06-13 | 2017-06-12 | 心臓弁修復装置およびその植込み方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11116635B2 (enExample) |
| EP (1) | EP3468506B1 (enExample) |
| JP (1) | JP7055992B2 (enExample) |
| KR (1) | KR102393787B1 (enExample) |
| CN (1) | CN109310500B (enExample) |
| AU (1) | AU2017285993B2 (enExample) |
| CA (1) | CA3027355A1 (enExample) |
| GB (1) | GB2566222B (enExample) |
| SG (2) | SG10202012104VA (enExample) |
| WO (1) | WO2017217932A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12138167B2 (en) * | 2016-06-13 | 2024-11-12 | Singapore Health Services Pte. Ltd. | Device for cardiac valve repair and method of implanting the same |
| WO2019195860A2 (en) | 2018-04-04 | 2019-10-10 | Vdyne, Llc | Devices and methods for anchoring transcatheter heart valve |
| WO2020026234A1 (en) * | 2018-07-29 | 2020-02-06 | Yair Feld | Transcatheter artificial cusp for valve insufficiency |
| CN112912033B (zh) * | 2018-08-22 | 2024-11-22 | 新加坡保健服务集团有限公司 | 瓣膜植入物、输送系统和方法 |
| US10321995B1 (en) | 2018-09-20 | 2019-06-18 | Vdyne, Llc | Orthogonally delivered transcatheter heart valve replacement |
| US11344413B2 (en) | 2018-09-20 | 2022-05-31 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
| US11071627B2 (en) | 2018-10-18 | 2021-07-27 | Vdyne, Inc. | Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis |
| US10595994B1 (en) | 2018-09-20 | 2020-03-24 | Vdyne, Llc | Side-delivered transcatheter heart valve replacement |
| US12186187B2 (en) | 2018-09-20 | 2025-01-07 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
| US11278437B2 (en) | 2018-12-08 | 2022-03-22 | Vdyne, Inc. | Compression capable annular frames for side delivery of transcatheter heart valve replacement |
| US11109969B2 (en) | 2018-10-22 | 2021-09-07 | Vdyne, Inc. | Guidewire delivery of transcatheter heart valve |
| CN119564381A (zh) * | 2018-12-06 | 2025-03-07 | 爱德华兹生命科学公司 | 单向瓣膜植入物 |
| US11253359B2 (en) | 2018-12-20 | 2022-02-22 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valves and methods of delivery |
| WO2020146842A1 (en) | 2019-01-10 | 2020-07-16 | Vdyne, Llc | Anchor hook for side-delivery transcatheter heart valve prosthesis |
| US11273032B2 (en) | 2019-01-26 | 2022-03-15 | Vdyne, Inc. | Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis |
| US11185409B2 (en) | 2019-01-26 | 2021-11-30 | Vdyne, Inc. | Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis |
| CN113631120A (zh) * | 2019-02-06 | 2021-11-09 | 奥盛有限责任公司 | 用于经导管瓣膜修复的锚定小叶装置和方法 |
| EP4364706B1 (en) | 2019-03-05 | 2025-12-03 | VDyne, Inc. | Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis |
| US11173027B2 (en) | 2019-03-14 | 2021-11-16 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
| US11076956B2 (en) | 2019-03-14 | 2021-08-03 | Vdyne, Inc. | Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis |
| CN120827457A (zh) | 2019-05-04 | 2025-10-24 | 维迪内股份有限公司 | 用于在自体瓣环中部署侧面递送的假体心脏瓣膜的束紧装置和方法 |
| KR102268993B1 (ko) * | 2019-05-16 | 2021-06-24 | (주) 타우피엔유메디칼 | 위치고정튜브를 구비한 삼첨판막 역류증 시술용 기구 |
| WO2020237182A1 (en) * | 2019-05-22 | 2020-11-26 | TriFlo Cardiovascular Inc. | Heart valve support device |
| JP2022536362A (ja) * | 2019-06-12 | 2022-08-15 | エドワーズ ライフサイエンシーズ コーポレイション | 左心房圧管理のための流体バイパス導管 |
| AU2020334080B2 (en) | 2019-08-20 | 2025-11-27 | Vdyne, Inc. | Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves |
| WO2021034538A1 (en) * | 2019-08-22 | 2021-02-25 | Edwards Lifesciences Corporation | Heart valve leaflet tethering |
| CN120531525A (zh) | 2019-08-26 | 2025-08-26 | 维迪内股份有限公司 | 可侧面输送的经导管假体瓣膜及其输送和锚定方法 |
| US11234813B2 (en) | 2020-01-17 | 2022-02-01 | Vdyne, Inc. | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery |
| IT202000012562A1 (it) | 2020-05-27 | 2021-11-27 | Milano Politecnico | Dispositivo e assieme per riparare una valvola cardiaca |
| AU2021349750A1 (en) * | 2020-09-28 | 2023-06-08 | Apparent Llc | Prosthetic implant, delivery system and delivery apparatus |
| US12414855B2 (en) * | 2020-11-20 | 2025-09-16 | Medtronic, Inc. | Tricuspid valve repair devices and associated systems and methods |
| EP4547162A2 (en) * | 2022-06-28 | 2025-05-07 | Singapore Health Services Pte Ltd | Coaptation device |
| US12171662B1 (en) | 2023-10-26 | 2024-12-24 | Approxima Srl | Heart chamber reshaping and valve repair system |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070198082A1 (en) | 2005-12-15 | 2007-08-23 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant valve |
| JP2008536592A (ja) | 2005-04-21 | 2008-09-11 | エドワーズ ライフサイエンシーズ アーゲー | 血流制御装置 |
| US20130325110A1 (en) | 2012-05-16 | 2013-12-05 | Edwards Lifesciences Corporation | Systems and methods for placing a coapting member between valvular leaflets |
| WO2014207575A2 (en) | 2013-06-14 | 2014-12-31 | Hazu Gmbh | Method and device for treatment of valve regurgitation |
| DE102013017750A1 (de) | 2013-10-28 | 2015-04-30 | Universität Duisburg-Essen | Implantierbare Vorrichtung zur Verbesserung oder Behebung einer Herzklappeninsuffizienz |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4994077A (en) * | 1989-04-21 | 1991-02-19 | Dobben Richard L | Artificial heart valve for implantation in a blood vessel |
| US8956407B2 (en) * | 2000-09-20 | 2015-02-17 | Mvrx, Inc. | Methods for reshaping a heart valve annulus using a tensioning implant |
| AU2002362442B2 (en) | 2001-10-01 | 2008-08-07 | Ample Medical, Inc. | Methods and devices for heart valve treatments |
| GB0125925D0 (en) * | 2001-10-29 | 2001-12-19 | Univ Glasgow | Mitral valve prosthesis |
| AU2003277115A1 (en) | 2002-10-01 | 2004-04-23 | Ample Medical, Inc. | Device and method for repairing a native heart valve leaflet |
| US7735493B2 (en) * | 2003-08-15 | 2010-06-15 | Atritech, Inc. | System and method for delivering a left atrial appendage containment device |
| WO2006041877A2 (en) * | 2004-10-05 | 2006-04-20 | Ample Medical, Inc. | Atrioventricular valve annulus repair systems and methods including retro-chordal anchors |
| US20100298929A1 (en) * | 2005-02-07 | 2010-11-25 | Thornton Troy L | Methods, systems and devices for cardiac valve repair |
| US8157853B2 (en) * | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
| EP3572044B1 (en) * | 2008-01-24 | 2021-07-28 | Medtronic, Inc. | Stents for prosthetic heart valves |
| US8475525B2 (en) * | 2010-01-22 | 2013-07-02 | 4Tech Inc. | Tricuspid valve repair using tension |
| US8657872B2 (en) * | 2010-07-19 | 2014-02-25 | Jacques Seguin | Cardiac valve repair system and methods of use |
| US8845717B2 (en) * | 2011-01-28 | 2014-09-30 | Middle Park Medical, Inc. | Coaptation enhancement implant, system, and method |
| US10271949B2 (en) * | 2013-03-12 | 2019-04-30 | St. Jude Medical, Cardiology Division, Inc. | Paravalvular leak occlusion device for self-expanding heart valves |
-
2017
- 2017-06-12 JP JP2018563776A patent/JP7055992B2/ja active Active
- 2017-06-12 SG SG10202012104VA patent/SG10202012104VA/en unknown
- 2017-06-12 AU AU2017285993A patent/AU2017285993B2/en active Active
- 2017-06-12 KR KR1020197001197A patent/KR102393787B1/ko active Active
- 2017-06-12 SG SG11201811019TA patent/SG11201811019TA/en unknown
- 2017-06-12 GB GB1900165.0A patent/GB2566222B/en active Active
- 2017-06-12 CA CA3027355A patent/CA3027355A1/en active Pending
- 2017-06-12 WO PCT/SG2017/050296 patent/WO2017217932A1/en not_active Ceased
- 2017-06-12 CN CN201780036727.7A patent/CN109310500B/zh active Active
- 2017-06-12 US US16/308,782 patent/US11116635B2/en active Active
- 2017-06-12 EP EP17813705.5A patent/EP3468506B1/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008536592A (ja) | 2005-04-21 | 2008-09-11 | エドワーズ ライフサイエンシーズ アーゲー | 血流制御装置 |
| US20070198082A1 (en) | 2005-12-15 | 2007-08-23 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant valve |
| US20130325110A1 (en) | 2012-05-16 | 2013-12-05 | Edwards Lifesciences Corporation | Systems and methods for placing a coapting member between valvular leaflets |
| WO2014207575A2 (en) | 2013-06-14 | 2014-12-31 | Hazu Gmbh | Method and device for treatment of valve regurgitation |
| DE102013017750A1 (de) | 2013-10-28 | 2015-04-30 | Universität Duisburg-Essen | Implantierbare Vorrichtung zur Verbesserung oder Behebung einer Herzklappeninsuffizienz |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3468506A1 (en) | 2019-04-17 |
| AU2017285993A1 (en) | 2019-01-03 |
| JP2019517346A (ja) | 2019-06-24 |
| KR20190020038A (ko) | 2019-02-27 |
| SG10202012104VA (en) | 2021-01-28 |
| GB2566222B (en) | 2022-04-06 |
| US20190142590A1 (en) | 2019-05-16 |
| EP3468506B1 (en) | 2024-07-31 |
| AU2017285993B2 (en) | 2021-12-16 |
| KR102393787B1 (ko) | 2022-05-03 |
| CA3027355A1 (en) | 2017-12-21 |
| US11116635B2 (en) | 2021-09-14 |
| SG11201811019TA (en) | 2019-01-30 |
| CN109310500A (zh) | 2019-02-05 |
| CN109310500B (zh) | 2021-11-19 |
| GB2566222A (en) | 2019-03-06 |
| WO2017217932A1 (en) | 2017-12-21 |
| EP3468506A4 (en) | 2020-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7055992B2 (ja) | 心臓弁修復装置およびその植込み方法 | |
| JP7341199B2 (ja) | 弁逆流症を経カテーテル治療するシステムおよび方法 | |
| US20250152344A1 (en) | Apparatus and method for replacing a diseased cardiac valve | |
| US10856858B2 (en) | Heart valve prosthesis and method | |
| JP6765409B2 (ja) | アンカーデバイスを備える装置 | |
| US7611534B2 (en) | Percutaneous atrioventricular valve and method of use | |
| AU2016380345B2 (en) | Systems and methods for heart valve therapy | |
| JP6773416B2 (ja) | 僧帽弁置換のための人工弁 | |
| US8685086B2 (en) | Apparatus and method for replacing a diseased cardiac valve | |
| CN111821069B (zh) | 心脏瓣膜 | |
| US11793628B2 (en) | Transcatheter bio-prosthesis member and support structure | |
| CN109789019A (zh) | 心脏瓣膜对接线圈和系统 | |
| JP2019524335A (ja) | 逆流のある心臓弁の弁尖を少なくとも部分的に支持するための装置及び方法 | |
| JP2017531547A (ja) | 心臓弁治療法のためのシステムおよび方法 | |
| CN118871044A (zh) | 双框架分流器 | |
| US12138167B2 (en) | Device for cardiac valve repair and method of implanting the same | |
| AU2014280916A1 (en) | Apparatus and method for replacing a diseased cardiac valve |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20190913 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200522 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200522 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210423 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210511 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210802 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211130 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220217 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220308 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220318 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7055992 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |